Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Vitamin D prevents clogged arteries in diabetics

14.11.2012
People with diabetes often develop clogged arteries that cause heart disease, and new research at Washington University School of Medicine in St. Louis suggests that low vitamin D levels are to blame.

In a study published Nov. 9 in the Journal of Biological Chemistry, the researchers report that blood vessels are less like to clog in people with diabetes who get adequate vitamin D. But in patients with insufficient vitamin D, immune cells bind to blood vessels near the heart, then trap cholesterol to block those blood vessels.


Bernal-Mizrachi lab

Low levels of vitamin D in people with diabetes appear to encourage cholesterol to build up in arteries, eventually blocking the flow of blood. In mice, immune cells adhering to the wall of a major blood vessel near the heart are loaded with cholesterol (shown in red).

“About 26 million Americans now have type 2 diabetes,” says principal investigator Carlos Bernal-Mizrachi, MD. “And as obesity rates rise, we expect even more people will develop diabetes. Those patients are more likely to experience heart problems due to an increase in vascular inflammation, so we have been investigating why this occurs.”

In earlier research, Bernal-Mizrachi, an assistant professor of medicine and of cell biology and physiology, and his colleagues found that vitamin D appears to play a key role in heart disease. This new study takes their work a step further, suggesting that when vitamin D levels are low, a particular class of white blood cell is more likely to adhere to cells in the walls of blood vessels.

Vitamin D conspires with immune cells called macrophages either to keep arteries clear or to clog them. The macrophages begin their existence as white blood cells called monocytes that circulate in the bloodstream. But when monocytes encounter inflammation, they are transformed into macrophages, which no longer circulate.

In the new study, researchers looked at vitamin D levels in 43 people with type 2 diabetes and in 25 others who were similar in age, sex and body weight but didn’t have diabetes.

They found that in diabetes patients with low vitamin D — less than 30 nanograms per milliliter of blood — the macrophage cells were more likely to adhere to the walls of blood vessels, which triggers cells to get loaded with cholesterol, eventually causing the vessels to stiffen and block blood flow.

“We took everything into account,” says first author Amy E. Riek, MD, instructor in medicine. “We looked at blood pressure, cholesterol, diabetes control, body weight and race. But only vitamin D levels correlated to whether these cells stuck to the blood vessel wall.”

Riek and Bernal-Mizrachi say what’s not yet clear is whether giving vitamin D to people with diabetes will reverse their risk of developing clogged arteries, a condition called atherosclerosis. They now are treating mice with vitamin D to see whether it can prevent monocytes from adhering to the walls of blood vessels near the heart, and they also are conducting two clinical trials in patients.

In one of those studies, the researchers are giving vitamin D to people with diabetes and hypertension to see whether the treatment may lower blood pressure. In the second study, African Americans with type 2 diabetes are getting vitamin D along with their other daily medications, and the research team is evaluating whether vitamin D supplements can slow or reverse the progression of heart disease.

Sometime in the next several months, the scientists hope to determine whether vitamin D treatment can reverse some of the risk factors associated with cardiovascular disease.

“In the future, we hope to generate medications, potentially even vitamin D itself, that help prevent the deposit of cholesterol in the blood vessels,” Bernal-Mizrachi explains. “Previous studies have linked vitamin D deficiency in these patients to increases in cardiovascular disease and in mortality. Other work has suggested that vitamin D may improve insulin release from the pancreas and insulin sensitivity. Our ultimate goal is to intervene in people with diabetes and to see whether vitamin D might decrease inflammation, reduce blood pressure and lessen the likelihood that they will develop atherosclerosis or other vascular complications.”

For more information on the current clinical studies involving vitamin D in people with diabetes, call study coordinator Robin Bruchas at (314) 362-0934.

Riek AE, Sprague JE, Timpson A, de las Fuentes L, Bernal-Mizrachi L, Schechtman KB, Bernal-Mizrachi C. Vitamin D suppression of endoplasmic reticulum stress promotes an anti-atherogenic monocyte/macrophage phenotype in type 2 diabetic patients. Journal of Biological Chemistry vol. 287 (46), pp. 38482-38494. Nov. 9, 2012

http://www.jbc.org/cgi/doi/10.1074/jbc.M112.386912

Funding for this research comes from the National Heart, Lung and Blood Institute (NHLBI), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Center for Research Resources (NCRR), National Center for Advancing Translational Sciences (NCATS), and NIH Roadmap for Medical Research of the National Institutes of Health (NIH). Support also comes from the American Diabetes Association, the Endocrine Society, the Endocrine Fellows Foundation and the Ruth L. Kirchstein National Research Service Award 2. NIH grant numbers are RO1 HO094818-0, P30DK079333, T32 HD043010, and UL1TRR000448/Sub-Award KL2TR000450.

Washington University School of Medicine’s 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children’s hospitals. The School of Medicine is one of the leading medical research, teaching and patient care institutions in the nation, currently ranked sixth in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children’s hospitals, the School of Medicine is linked to BJC HealthCare.

Jim Dryden | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Life Sciences:

nachricht Molecular Spies Sabotage a Protein's Activities in Specific Cellular Compartments
20.04.2015 | Johns Hopkins Medicine

nachricht Evolution puts checks on virgin births
20.04.2015 | Okinawa Institute of Science and Technology (OIST) Graduate University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Get flexible – get lighter – get smarter – Innovative Materialien für Zukunftsprodukte

Das Fraunhofer-Institut für Silicatforschung ISC aus Würzburg stellt auf der IDTechEx in Berlin vom 28. bis 29. April 2015 neue, multifunktionale Materialien vor, mit denen sich innovative Anwendungen und Produkte realisieren lassen. Arbeitsschwerpunkte sind Barrierematerialien, gedruckte Elektronik, elektrochrome Folien sowie Smart Materials. Sie bedienen die Trends in Industrie und Design zu immer flexibleren, leichteren und intelligenteren Produkten. Das Fraunhofer ISC ist am Stand F17 im Convention Center und Hotel Estrel zu finden.

Präsentiert werden beispielsweise innovative Verkapselungsfolien, die das Fraunhofer ISC zusammen mit dem Fraunhofer IVV entwickelt hat. Die kostengünstig im...

Im Focus: Advances in Molecular Electronics: Lights On – Molecule On

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the University of Konstanz are working on storing and processing information on the level of single molecules to create the smallest possible components that will combine autonomously to form a circuit. As recently reported in the academic journal Advanced Science, the researchers can switch on the current flow through a single molecule for the first time with the help of light.

Dr. Artur Erbe, physicist at the HZDR, is convinced that in the future molecular electronics will open the door for novel and increasingly smaller – while also...

Im Focus: Fortschritt für die molekulare Elektronik: Licht an – Molekül an

Mit einzelnen Molekülen Informationen zu speichern und verarbeiten, um daraus kleinstmögliche Bausteine zu entwickeln, die sich selbstständig zu einem Schaltkreis zusammensetzen – daran arbeiten Wissenschaftler des Helmholtz-Zentrums Dresden-Rossendorf (HZDR) und der Universität Konstanz. Wie sie nun in der Fachzeitschrift „Advanced Science“ berichten, konnten sie erstmalig den Stromfluss durch ein einzelnes Molekül mit Hilfe von Licht einschalten.

Die molekulare Elektronik wird zukünftig ein Fenster hin zu neuartigen und immer noch kleineren und zugleich energieeffizienten Bauelementen oder Sensoren...

Im Focus: Wie Blutgefässe veröden: Zellen verschmelzen mit sich selbst

Zellen im Blutgefäßsystem von Wirbeltieren können mit sich selbst verschmelzen. Diesen Prozess, der auftritt, wenn ein Blutgefäß nicht mehr benötigt und zurückgebildet wird, hat das Forschungsteam von Prof. Markus Affolter am Biozentrum der Universität Basel erstmals auf zellulärer Ebene beschrieben. Die Ergebnisse der Studie sind im Fachjournal «PLoS Biology» veröffentlicht.

Blutgefässe bilden das Versorgungsnetzwerk des menschlichen Organismus. Sie versorgen ihn mit Sauerstoff und Nährstoffen bis in den letzten Winkel jedes...

Im Focus: Pruning of Blood Vessels: Cells Can Fuse With Themselves

Cells of the vascular system of vertebrates can fuse with themselves. This process, which occurs when a blood vessel is no longer necessary and pruned, has now been described on the cellular level by Prof. Markus Affolter from the Biozentrum of the University of Basel. The findings of this study have been published in the journal “PLoS Biology”.

The vascular system is the supply network of the human organism and delivers oxygen and nutrients to the last corners of the body. So far, research on the...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Zurück zu den Wurzeln – größte nationale Tagung für Nuklearmedizin in Hannover

20.04.2015 | Veranstaltungen

DFG-UNU-Konferenz in New York: Wie kann Wissenschaft zur globalen Nachhaltigkeit beitragen?

20.04.2015 | Veranstaltungen

Mehr Schutz vor Krankenhauskeimen

20.04.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Meeresströmungen beeinflussen Methanabbau

20.04.2015 | Geowissenschaften

Bahnbrechende Erkenntnis: Robben interpretieren ihre eigene Bewegung

20.04.2015 | Biowissenschaften Chemie

Earth Day 2015 - Platin dreht sich immer im Kreis

20.04.2015 | Ökologie Umwelt- Naturschutz